Arsenic Trioxide in Combination with All-Trans Retinoic Acid for the Treatment of Newly Diagnosed Patients with High-Risk APL By Ogkologos - September 3, 2025 582 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the APOLLO study Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR Health inequalities: breaking down barriers to cancer screening September 23, 2022 A Congress Bag for Women’s Empowerment March 9, 2020 Plant-Based Diets and a New Treatment Combination for Prostate Cancer: Research... February 16, 2023 Study Links Breast Cancer Spread to Newly Discovered RNA Splicing Mechanism May 21, 2021 Load more HOT NEWS This Breast Cancer Patient Is Using Boudoir Photography to Reclaim Her... One in Five of Older Patients with EBC Treated in a... Mutational Patterns Drive Metastatic Aggressiveness of Appendiceal Adenocarcinomas Dalpiciclib plus Fulvestrant in Pretreated HR-positive, HER2-negative Advanced Breast Cancer
